These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 3409213

  • 1. Delivery of melanoma-associated immunoglobulin monoclonal antibody and Fab fragments to normal brain utilizing osmotic blood-brain barrier disruption.
    Neuwelt EA, Barnett PA, Hellström I, Hellström KE, Beaumier P, McCormick CI, Weigel RM.
    Cancer Res; 1988 Sep 01; 48(17):4725-9. PubMed ID: 3409213
    [Abstract] [Full Text] [Related]

  • 2. Direct stereotactic intracerebral injection of monoclonal antibodies and their fragments: a potential approach to brain tumor immunotherapy.
    Liebert M, Wahl RL, Lawless G, McKeever PE, Taren JA, Beierwaltes WH, Brasswell R.
    Am J Physiol Imaging; 1990 Sep 01; 5(2):55-9. PubMed ID: 2252605
    [Abstract] [Full Text] [Related]

  • 3. Anti-phencyclidine monoclonal antibodies provide long-term reductions in brain phencyclidine concentrations during chronic phencyclidine administration in rats.
    Proksch JW, Gentry WB, Owens SM.
    J Pharmacol Exp Ther; 2000 Mar 01; 292(3):831-7. PubMed ID: 10688594
    [Abstract] [Full Text] [Related]

  • 4. Transcytosis of protein through the mammalian cerebral epithelium and endothelium. III. Receptor-mediated transcytosis through the blood-brain barrier of blood-borne transferrin and antibody against the transferrin receptor.
    Broadwell RD, Baker-Cairns BJ, Friden PM, Oliver C, Villegas JC.
    Exp Neurol; 1996 Nov 01; 142(1):47-65. PubMed ID: 8912898
    [Abstract] [Full Text] [Related]

  • 5. Osmotic blood-brain barrier opening to IgM monoclonal antibody in the rat.
    Neuwelt EA, Minna J, Frenkel E, Barnett PA, McCormick CI.
    Am J Physiol; 1986 May 01; 250(5 Pt 2):R875-83. PubMed ID: 3706572
    [Abstract] [Full Text] [Related]

  • 6. Increased delivery of tumor-specific monoclonal antibodies to brain after osmotic blood-brain barrier modification in patients with melanoma metastatic to the central nervous system.
    Neuwelt EA, Specht HD, Barnett PA, Dahlborg SA, Miley A, Larson SM, Brown P, Eckerman KF, Hellström KE, Hellström I.
    Neurosurgery; 1987 Jun 01; 20(6):885-95. PubMed ID: 3112602
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antiphencyclidine monoclonal antibody therapy significantly changes phencyclidine concentrations in brain and other tissues in rats.
    Valentine JL, Owens SM.
    J Pharmacol Exp Ther; 1996 Aug 01; 278(2):717-24. PubMed ID: 8768723
    [Abstract] [Full Text] [Related]

  • 9. Colchicine-specific Fab fragments alter colchicine disposition in rabbits.
    Sabouraud AE, Urtizberea M, Cano NJ, Grandgeorge M, Rouzioux JM, Scherrmann JM.
    J Pharmacol Exp Ther; 1992 Mar 01; 260(3):1214-9. PubMed ID: 1545388
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Biodistribution of monoclonal IgG1, F(ab')2, and Fab' in mice after intravenous injection. Comparison between anti-B cell (anti-Lyb8.2) and irrelevant (MOPC-21) antibodies.
    Holton OD, Black CD, Parker RJ, Covell DG, Barbet J, Sieber SM, Talley MJ, Weinstein JN.
    J Immunol; 1987 Nov 01; 139(9):3041-9. PubMed ID: 3499463
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Delivery of human interferon-alpha to brain by transient osmotic blood-brain barrier modification in the rat.
    Greig NH, Fredericks WR, Holloway HW, Soncrant TT, Rapoport SI.
    J Pharmacol Exp Ther; 1988 May 01; 245(2):581-6. PubMed ID: 3367308
    [Abstract] [Full Text] [Related]

  • 18. Immunopharmacological activity of monoclonal antidigitoxin.
    Urtizberea M, Latour M, Edelman L, Carcagne J, Armand J, Scherrmann JM.
    Dev Biol Stand; 1990 May 01; 71():147-57. PubMed ID: 2401380
    [Abstract] [Full Text] [Related]

  • 19. Use of neutral avidin improves pharmacokinetics and brain delivery of biotin bound to an avidin-monoclonal antibody conjugate.
    Kang YS, Pardridge WM.
    J Pharmacol Exp Ther; 1994 Apr 01; 269(1):344-50. PubMed ID: 8169841
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.